| # | Security | Value | Shares | % Port | Change | Δ Shares |
|---|---|---|---|---|---|---|
| 1 | AURINIA PHARMACEUTICALS INC COM | $181.2M | 12.23M | 9.2% | ADDED | +900.0K |
| 2 | CELCUITY INC COM | $119.8M | 1.05M | 6.1% | —HELD | 0 |
| 3 | MIRUM PHARMACEUTICALS INC COM | $114.2M | 1.24M | 5.8% | —HELD | 0 |
| 4 | GALAPAGOS NV SPON ADR | $113.6M | 3.79M | 5.8% | REDUCED | -135,228 |
| 5 | STATE STR SPDR S&P 500 ETF T TR UNIT | $109.3M | 168.0K | 5.5% | ADDED | +138.0K |
| 6 | KINIKSA PHARMACEUTICALS INTL ORD SHS CL A | $108.8M | 2.26M | 5.5% | —HELD | 0 |
| 7 | CAPRICOR THERAPEUTICS INC COM NEW | $103.4M | 3.40M | 5.2% | ADDED | +1.70M |
| 8 | PTC THERAPEUTICS INC COM | $102.2M | 1.50M | 5.2% | —HELD | 0 |
| 9 | SPYRE THERAPEUTICS INC COM NEW | $95.4M | 1.89M | 4.8% | —HELD | 0 |
| 10 | KALVISTA PHARMACEUTICALS INC COM | $92.1M | 4.57M | 4.7% | —HELD | 0 |
| 11 | COMPASS THERAPEUTICS INC COM | $88.8M | 16.79M | 4.5% | —HELD | 0 |
| 12 | TARSUS PHARMACEUTICALS INC COM | $83.4M | 1.19M | 4.2% | —HELD | 0 |
| 13 | IMMUNOCORE HLDGS PLC ADS | $79.9M | 2.65M | 4.1% | ADDED | +20.8K |
| 14 | ANAPTYSBIO INC COM | $73.8M | 1.33M | 3.7% | REDUCED | -1,208 |
| 15 | CORCEPT THERAPEUTICS INC COM | $60.5M | 1.50M | 3.1% | ADDED | +1.34M |
| 16 | ANI PHARMACEUTICALS INC COM | $54.4M | 707.5K | 2.8% | ADDED | +226.1K |
| 17 | INSMED INC COM PAR $.01 | $42.5M | 260.0K | 2.2% | ADDED | +200.0K |
| 18 | BIONTECH SE SPONSORED ADS | $41.8M | 470.0K | 2.1% | —HELD | 0 |
| 19 | VIRIDIAN THERAPEUTICS INC COM | $35.1M | 1.79M | 1.8% | —HELD | 0 |
| 20 | ATEA PHARMACEUTICALS INC COM | $25.9M | 4.81M | 1.3% | —HELD | 0 |
| 21 | PRECIGEN INC COM | $24.8M | 6.42M | 1.3% | ADDED | +800.0K |
| 22 | DIANTHUS THERAPEUTICS INC COM | $22.2M | 264.7K | 1.1% | —HELD | 0 |
| 23 | COMPASS PATHWAYS PLC SPONSORED ADS | $22.1M | 4.00M | 1.1% | NEW | — |
| 24 | CRESCENT BIOPHARMA INC. COM | $21.3M | 1.16M | 1.1% | ADDED | +287.6K |
| 25 | STOKE THERAPEUTICS INC COM | $16.3M | 500.0K | 0.8% | —HELD | 0 |
Holdings data sourced from SEC EDGAR 13F-HR filings. Updated quarterly, approximately 45 days after quarter end. All data is public domain.
Last filed: May 15, 2026